Octreotide scanning is increasingly being used to detect tumours with
somatostatin receptors. Moreover, there is growing interest in the use
of somatostatin analogues for the treatment of tumours with somatosta
tin receptors. This review documents the use at our institution of the
octreotide scan in three patients with intrathoracic pathology, and c
omments on overall experience in the literature with this technology.